161 related articles for article (PubMed ID: 38317679)
1. Uncovering the armpit of SBRT: An institutional experience with stereotactic radiation of axillary metastases.
Mutsaers A; Li GJ; Fernandes JS; Ali S; Barnes EA; Chen H; Czarnota GJ; Karam I; Moore-Palhares D; Poon I; Soliman H; Vesprini D; Cheung P; Louie AV
Clin Transl Radiat Oncol; 2024 Mar; 45():100730. PubMed ID: 38317679
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
Shahi J; Poon I; Ung YC; Tsao M; Bjarnason GA; Malik NH; Zhang L; Louie AV; Cheung P
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):764-774. PubMed ID: 33115687
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy for distant metastases to the head and neck.
Mutsaers A; Abugharib A; Poon I; Loblaw J; Bayley A; Zhang L; Chin L; Galapin M; Erler D; Sahgal A; Higgins K; Enepekides D; Eskander A; Karam I
Support Care Cancer; 2024 Mar; 32(4):230. PubMed ID: 38488881
[TBL] [Abstract][Full Text] [Related]
4. Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy?
Merino Lara T; Helou J; Poon I; Sahgal A; Chung HT; Chu W; Soliman H; Ung Y; Verma S; Cheema P; Cheng S; Khanna S; Erler D; Zhang L; Cheung P
Lung Cancer; 2018 Oct; 124():219-226. PubMed ID: 30268464
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.
Helou J; Thibault I; Poon I; Chiang A; Jain S; Soliman H; Erler D; Yeung L; Cheung P
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):419-427. PubMed ID: 28463162
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review.
Li GJ; Tan H; Nusrat H; Chang J; Chen H; Poon I; Shahi J; Tsao M; Ung Y; Cheung P; Louie AV
Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38621607
[TBL] [Abstract][Full Text] [Related]
7. Five- Versus Ten-Fraction Regimens of Stereotactic Body Radiation Therapy for Primary and Metastatic NSCLC.
Steber CR; Hughes RT; Soike MH; Jacobson T; Helis CA; Farris JC; Farris MK
Clin Lung Cancer; 2021 Jan; 22(1):e122-e131. PubMed ID: 33046359
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer.
Li S; Dong D; Geng J; Zhu X; Shi C; Zhang Y; Wang H; Zhou S; Wu H; Cai Y; Li Y; Wang W
Front Oncol; 2019; 9():1080. PubMed ID: 31681609
[No Abstract] [Full Text] [Related]
9. Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer.
Xu B; Zhao X; Chen D; Zhao W; Wang X; Ding C; Yuan Z; Zhang H
BMC Cancer; 2023 Jan; 23(1):73. PubMed ID: 36681809
[TBL] [Abstract][Full Text] [Related]
10. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy.
Nguyen EK; Poon I; Ung YC; Tsao M; Korol R; Elzibak AH; Erler D; Zhang L; Louie AV; Cheung P
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):897-905. PubMed ID: 36368432
[TBL] [Abstract][Full Text] [Related]
13. Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases.
Anstadt EJ; Shumway R; Colasanto J; Grew D
J Gastrointest Oncol; 2019 Apr; 10(2):330-338. PubMed ID: 31032102
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication matters.
Tan H; Cheung P; Louie AV; Myrehaug S; Niglas M; Atenafu EG; Chu W; Chung HT; Poon I; Sahgal A; Soliman H
Radiother Oncol; 2021 Aug; 161():159-165. PubMed ID: 34119585
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter.
Thompson R; Cheung P; Chu W; Myrehaug S; Poon I; Sahgal A; Soliman H; Tseng CL; Wong S; Ung Y; Beatriz Kinupe Abrahão A; Erler D; Zhang L; Ko YJ; Chung HT
Radiother Oncol; 2020 Jan; 142():236-245. PubMed ID: 31543287
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a single institution's experience.
Chai G; Yin Y; Zhou X; Hu Q; Lv B; Li Z; Shi M; Zhao L
Transl Lung Cancer Res; 2020 Aug; 9(4):1496-1506. PubMed ID: 32953521
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Radiotherapy for Adrenal Metastases: A Multi-Institutional Review of Patient Characteristics and Outcomes - Turkish Society for Radiation Oncology SBRT Group Study (Trod SBRT 10-004).
Elmali A; Akkus Yildirim B; Cengiz M; Yuce Sari S; Onal HC; Berber T; Arslantas Erken A; Zoto Mustafayev T; Atalar B; Unal I; Kaydihan N; Oner Dincbas F
Oncol Res Treat; 2022; 45(12):717-727. PubMed ID: 36116432
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Stereotactic Body Radiotherapy for Metastatic Colorectal Cancer With Oligometastases, Oligoprogression, or Local Control of Dominant Tumors.
Ji X; Zhao Y; Zhu X; Shen Z; Li A; Chen C; Chu X
Front Oncol; 2020; 10():595781. PubMed ID: 33585211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]